
|Videos|July 11, 2023
PSMA-Based Imaging and Theranostics: A Summary of Current Paradigm Shifts and a Look to the Future
The panel discusses the possibility of PSMA-PET becoming the standard-of-care imaging modality for prostate cancer, which may obviate the need for conventional imaging and bone scans, and then touches on the increasing availability of PSMA-targeted radiotherapies.
Advertisement
Episodes in this series

Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA updates in urology: December 2025
2
Daniel Spratt, MD, on using ArteraAI to guide salvage therapy decisions
3
The UroOnc Minute: En bloc resection vs TURBT, with Jeremy Y.C. Teoh, MBBS, FRCSEd, FCSHK, FHKAM
4
Top 10 Urology Times bladder cancer articles of 2025
5























